Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Panobinostat> ?p ?o. }
Showing items 1 to 64 of
64
with 100 items per page.
- Panobinostat abstract "Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (HDAC inhibitor).".
- Panobinostat atcPrefix "L01".
- Panobinostat atcSuffix "XX42".
- Panobinostat casNumber "404950-80-7".
- Panobinostat fdaUniiCode "9647FM7Y3Z".
- Panobinostat iupacName "(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide".
- Panobinostat pubchem "6918837".
- Panobinostat thumbnail Panobinostat_structure.svg?width=300.
- Panobinostat wikiPageID "20845241".
- Panobinostat wikiPageRevisionID "604931023".
- Panobinostat atcPrefix "L01".
- Panobinostat atcSuffix "XX42".
- Panobinostat c "21".
- Panobinostat casNumber "404950".
- Panobinostat chemspiderid "5294028".
- Panobinostat h "23".
- Panobinostat hasPhotoCollection Panobinostat.
- Panobinostat iupacName "-N-hydroxy-3-[4-phenyl]acrylamide".
- Panobinostat kegg "D10019".
- Panobinostat legalStatus "Experimental".
- Panobinostat molecularWeight "349.42622".
- Panobinostat n "3".
- Panobinostat o "2".
- Panobinostat pubchem "6918837".
- Panobinostat routesOfAdministration "Oral".
- Panobinostat smiles "O=C\C=C\c1cccCNCCc3c2ccccc2nc3C".
- Panobinostat stdinchi "1".
- Panobinostat stdinchikey "FPOHNWQLNRZRFC-ZHACJKMWSA-N".
- Panobinostat unii "9647".
- Panobinostat verifiedfields "changed".
- Panobinostat verifiedrevid "455315413".
- Panobinostat watchedfields "changed".
- Panobinostat subject Category:Experimental_cancer_drugs.
- Panobinostat subject Category:Histone_deacetylase_inhibitors.
- Panobinostat subject Category:Hydroxamic_acids.
- Panobinostat subject Category:Indoles.
- Panobinostat type Agent114778436.
- Panobinostat type Antineoplastic102722458.
- Panobinostat type CausalAgent100007347.
- Panobinostat type CytotoxicDrug103157987.
- Panobinostat type Drug103247620.
- Panobinostat type ExperimentalCancerDrugs.
- Panobinostat type HistoneDeacetylaseInhibitors.
- Panobinostat type Inhibitor114724436.
- Panobinostat type Matter100020827.
- Panobinostat type Medicine103740161.
- Panobinostat type PhysicalEntity100001930.
- Panobinostat type Substance100020090.
- Panobinostat type Drug.
- Panobinostat type DrugProduct.
- Panobinostat type FunctionalSubstance.
- Panobinostat comment "Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (HDAC inhibitor).".
- Panobinostat label "Panobinostat".
- Panobinostat label "Panobinostat".
- Panobinostat label "Panobinostat".
- Panobinostat sameAs Panobinostat.
- Panobinostat sameAs Panobinostat.
- Panobinostat sameAs m.053d6k0.
- Panobinostat sameAs Q7131441.
- Panobinostat sameAs Q7131441.
- Panobinostat sameAs Panobinostat.
- Panobinostat wasDerivedFrom Panobinostat?oldid=604931023.
- Panobinostat depiction Panobinostat_structure.svg.
- Panobinostat isPrimaryTopicOf Panobinostat.